CWM, LLC

Position in RGNX — REGENXBIO Inc.

CIK 1535847 OMAHA, NE

Position in RGNX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$604,323

-$459,232 QoQ

Shares Held

72,115

-2.4% QoQ

Ownership

0.139%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 4.605144560770991.ToString("F0")% Shared 0.ToString("F0")% None 95.394855439229.ToString("F0")%

Healthcare · as of Mar 31, 2026

CWM, LLC holds $170,074,719 across 302 Biotechnology names. RGNX ranks #29 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	66,400	$51,303,296
2	MRNA	Moderna, Inc.	386,906	$19,654,824
3	INCY	Incyte Corp	202,772	$19,084,900
4	EXEL	Exelixis, Inc.	263,476	$11,300,485
5	BMRN	Biomarin Pharmaceutical Inc	159,652	$9,018,741
6	ROIV	Roivant Sciences Ltd.	181,899	$5,038,602
7	SRPT	Sarepta Therapeutics, Inc.	198,333	$4,315,726
8	VRTX	Vertex Pharmaceuticals Inc / Ma	8,609	$3,844,262

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$604,323	72,115	-2.4%	Shares	Sole	2026-05-14
2025-12-31	$1,063,555	73,858	+8.6%	Shares	Sole	2026-01-26
2025-09-30	$656,537	68,035	+45.3%	Shares	Sole	2025-10-15
2025-06-30	$384,359	46,816	+75.4%	Shares	Sole	2025-07-25
2025-03-31	$190,876	26,696	+6181.4%	Shares	Sole	2025-05-01
2024-12-31	$3,285	425	-43.9%	Shares	Sole	2025-02-04
2024-09-30	$7,940	757	-11.5%	Shares	Sole	2024-10-08
2024-06-30	$10,003	855	+61.0%	Shares	Sole	2024-07-10
2024-03-31	$11,188	531	+3218.8%	Shares	Sole	2024-04-05
2023-12-31	$287	16	-62.8%	Shares	Sole	2024-02-01
2023-06-30	$859	43	+616.7%	Shares	Sole	2023-08-03
2023-03-31	$113	6	-96.6%	Shares	Sole	2023-05-01
2022-12-31	$3,969	175	+30.6%	Shares	Sole	2023-02-01
2022-09-30	$3,541	134	-15.2%	Shares	Sole	2022-10-27
2021-12-31	$5,166	158	—	Shares	Sole	2022-01-31
No filing history on record for this holder in this stock.